Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546026 | SCV000656019 | benign | Noonan syndrome 9 | 2024-12-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193057 | SCV001361621 | benign | not specified | 2019-09-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431705 | SCV002743122 | benign | Cardiovascular phenotype | 2019-12-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000546026 | SCV002763032 | benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing |